• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Acorda Therapeutics

Acorda Therapeutics

  1. Acorda Presenting New Tozadenant Data at 2017 MDS Congress

    Acorda Presenting New Tozadenant Data at 2017 MDS Congress

  2. Acorda stock surges 10% on positive late-stage Parkinson's results

    Acorda stock surges 10% on positive late-stage Parkinson's results

  3. BIO Elects John Maraganore, Ph.D., as New Chair

    BIO Elects John Maraganore, Ph.D., as New Chair

©2017 Morningstar Advisor. All right reserved.